- 數(shù)據(jù)庫(kù)收錄SCIE
- 年發(fā)文量194
Cardiovascular Revascularization Medicine
期刊中文名：心血管血運(yùn)重建醫(yī)學(xué)ISSN：1553-8389E-ISSN：1878-0938
該雜志國(guó)際簡(jiǎn)稱：CARDIOVASC REVASCULA，是由出版商Elsevier出版的一本致力于發(fā)布--研究新成果的的專(zhuān)業(yè)學(xué)術(shù)期刊。主要發(fā)表刊登有創(chuàng)見(jiàn)的學(xué)術(shù)論文文章、行業(yè)最新科研成果，扼要報(bào)道階段性研究成果和重要研究工作的最新進(jìn)展，選載對(duì)學(xué)科發(fā)展起指導(dǎo)作用的綜述與專(zhuān)論，促進(jìn)學(xué)術(shù)發(fā)展，為廣大讀者服務(wù)。該刊是一本國(guó)際優(yōu)秀雜志，在國(guó)際上有很高的學(xué)術(shù)影響力。
雜志介紹
Cardiovascular Revascularization Medicine雜志介紹
《Cardiovascular Revascularization Medicine》是一本以English為主的未開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱心血管血運(yùn)重建醫(yī)學(xué)，本刊主要出版、報(bào)道領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專(zhuān)業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專(zhuān)業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為1.6，最新CiteScore 指數(shù)為3.3。
本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：
-
In-Hospital Heart Failure in Patients With Takotsubo Cardiomyopathy Due to Coronary Artery Disease: An Artificial Intelligence and Optical Coherence Tomography Study
Author: Kumar, Sant; Chu, Miao; Sans-Rosello, Jordi; Fernandez-Peregrina, Estefania; Kahsay, Yirga; Gonzalo, Nieves; Salazar, Carlos Hernando; Alfonso, Fernando; Tu, Shengxian; Garcia-Garcia, Hector M.
英文介紹
Cardiovascular Revascularization Medicine雜志英文介紹
Cardiovascular Revascalization Medicine is an academic journal dedicated to the field of cardiovascular reconstruction medicine, aiming to provide a platform for cardiovascular disease experts, cardiovascular surgeons, interventional cardiologists, and other related medical professionals to exchange and share the latest research results, clinical experience, and technological innovations. The magazine covers various aspects of cardiovascular reconstruction medicine, including coronary artery disease, peripheral vascular disease, carotid artery disease, venous disease, etc. The article types are rich and diverse, including original research papers, review articles, case reports, technological advances, guidelines, and consensus, providing readers with the latest research trends, clinical practices, and technological developments in cardiovascular reconstruction medicine. The magazine is committed to promoting the development of cardiovascular reconstruction medicine, improving the diagnosis and treatment of cardiovascular diseases, encouraging innovative thinking, supporting interdisciplinary cooperation, and promoting scientific research and technological progress in the field of cardiovascular reconstruction medicine. By publishing high-quality research papers and review articles, this journal provides a platform for cardiovascular disease experts to understand the latest research results, master clinical skills, and improve diagnosis and treatment levels.
JCR分區(qū)（2023-2024年最新版）
Cardiovascular Revascularization Medicine雜志 JCR分區(qū)信息
| 按JIF指標(biāo)學(xué)科分區(qū) |
學(xué)科：CARDIAC & CARDIOVASCULAR SYSTEMS
收錄子集：ESCI
分區(qū)：Q3
排名：137 / 220
百分位：
38% |
| 按JCI指標(biāo)學(xué)科分區(qū) |
學(xué)科：CARDIAC & CARDIOVASCULAR SYSTEMS
收錄子集：ESCI
分區(qū)：Q3
排名：120 / 220
百分位：
45.68% |
JCR分區(qū)：JCR分區(qū)來(lái)自科睿唯安公司,JCR是一個(gè)獨(dú)特的多學(xué)科期刊評(píng)價(jià)工具，為唯一提供基于引文數(shù)據(jù)的統(tǒng)計(jì)信息的期刊評(píng)價(jià)資源。每年發(fā)布的JCR分區(qū)，設(shè)置了254個(gè)具體學(xué)科。JCR分區(qū)根據(jù)每個(gè)學(xué)科分類(lèi)按照期刊當(dāng)年的影響因子高低將期刊平均分為4個(gè)區(qū)，分別為Q1、Q2、Q3和Q4，各占25%。JCR分區(qū)中期刊的數(shù)量是均勻分為四個(gè)部分的。
CiteScore 評(píng)價(jià)數(shù)據(jù)（2024年最新版）
Cardiovascular Revascularization Medicine雜志CiteScore 評(píng)價(jià)數(shù)據(jù)
- CiteScore 值：3.3
- SJR：0.493
- SNIP：0.597
| 學(xué)科類(lèi)別 | 分區(qū) | 排名 | 百分位 |
| 大類(lèi)：Medicine 小類(lèi)：Cardiology and Cardiovascular Medicine | Q2 | 188 / 387 |
51% |
歷年影響因子和期刊自引率
投稿經(jīng)驗(yàn)
Cardiovascular Revascularization Medicine雜志投稿經(jīng)驗(yàn)
該雜志是一本國(guó)際優(yōu)秀雜志，在國(guó)際上有較高的學(xué)術(shù)影響力，行業(yè)關(guān)注度很高，已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，該雜志在綜合專(zhuān)業(yè)領(lǐng)域?qū)I(yè)度認(rèn)可很高，對(duì)稿件內(nèi)容的創(chuàng)新性和學(xué)術(shù)性要求很高，作為一本國(guó)際優(yōu)秀雜志，一般投稿過(guò)審時(shí)間都較長(zhǎng)，投稿過(guò)審時(shí)間平均 ，如果想投稿該刊要做好時(shí)間安排。版面費(fèi)不祥。該雜志近兩年未被列入預(yù)警名單，建議您投稿。如您想了解更多投稿政策及投稿方案，請(qǐng)咨詢客服。
免責(zé)聲明
若用戶需要出版服務(wù)，請(qǐng)聯(lián)系出版商。